The G2 Checkpoint Inhibitor CBP-93872 Increases the Sensitivity of Colorectal and Pancreatic Cancer Cells to Chemotherapy

PLoS ONE - United States
doi 10.1371/journal.pone.0178221
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

P16 Methylation Increases the Sensitivity of Cancer Cells to the CDK4/6 Inhibitor Palbociclib

PLoS ONE
Multidisciplinary
2019English

P16 Methylation Increases the Sensitivity of Cancer Cells to the CDK4/6 Inhibitor Palbociclib

2019English

EGFR Inhibitor C225 Increases the Radio-Sensitivity of Human Breast Cancer Cells

Asian Pacific Journal of Cancer Prevention
2019English

Inhibition of ATR Increases the Sensitivity to WEE1 Inhibitor in Biliary Tract Cancer

Cancer Research and Treatment
Cancer ResearchOncology
2020English

Knockdown of MTDH Increases Drug Sensitivity to HDAC Inhibitor and TRAIL Combination Treatment in Endometrial Cancer Cells

Proceedings in Obstetrics and Gynecology
2011English

PARP Inhibition Sensitizes Colorectal Cancer-Initiating Cells to Chemotherapy

Stem Cells
MedicineMolecular MedicineDevelopmental BiologyCell Biology
2018English

BML-275, an AMPK Inhibitor, Induces DNA Damage, G2/M Arrest and Apoptosis in Human Pancreatic Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2012English

WEE1 Kinase Inhibition Reverses G2/M Cell Cycle Checkpoint Activation to Sensitize Cancer Cells to Immunotherapy

OncoImmunology
OncologyAllergyImmunology
2018English

Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling

Scientific Reports
Multidisciplinary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy